MoonLake Immunotherapeutics
MLTX
#5852
Rank
โ‚ฌ1.13 B
Marketcap
13,33ย โ‚ฌ
Share price
1.24%
Change (1 day)
-71.61%
Change (1 year)

EPS for MoonLake Immunotherapeutics (MLTX)

EPS in 2026 (TTM): -3,10ย โ‚ฌ

According to MoonLake Immunotherapeutics's latest financial reports the company's current EPS (TTM) is -3,07ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -1,62ย โ‚ฌ.

EPS history for MoonLake Immunotherapeutics from 2022 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-3,10ย โ‚ฌ
2024-1,62ย โ‚ฌ
2022-1,16ย โ‚ฌ